Latest News and Articles

Ultragenyx partners with GeneTx for antisense technology

Ultragenyx partners with GeneTx for antisense technology

Published: 19th August 2019 - 11:53 am
FDA ditches Sarepta’s antisense oligonucleotide treatment for DMD

FDA ditches Sarepta’s antisense oligonucleotide treatment for DMD

Published: 21st August 2019 - 8:33 am
Lentiviral gene therapy shows clinical benefit in macaque models of Parkinson’s disease

Lentiviral gene therapy shows clinical benefit in macaque models of Parkinson’s disease

Published: 22nd August 2019 - 10:53 am
Pfizer invests $500 million in new gene therapy facility in Sanford, NC

Pfizer invests $500 million in new gene therapy facility in Sanford, NC

Published: 23rd August 2019 - 7:17 am
CGTI

CELL & GENE THERAPY INSIGHTS

Senior Editor: Prof. Chris Mason, AVROBIO and UCL, UK
The peer-reviewed, open access publication bringing you the latest research, reviews and updates from across the sector

Read more 

BioInsights – the publisher of Cell & Gene Therapy Insights

– is your content marketing partner for life sciences.

Sponsorship